Overview

• Mallinckrodt plans to file for bankruptcy protection for the second time in three years.
• Mallinckrodt recently signed a restructuring agreement to pay $250 million to an opioids victims trust, down from $1.7 billion.
• Mallinckrodt will reduce its total debt by about $1.9 billion as part of the agreement.
• Victims who would have received about $160 million under the original settlement may now receive only $50-60 million.
• Mallinckrodt is one of the largest manufacturers of opioids and also produces generic and branded drugs.